| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |